New Drug Is Effective In Reducing Rejection In Heart Transplant

Armen Hareyan's picture

Heart Transplant

A new study shows that a drug, called daclizumab, is effective at reducing organ rejection and risk of infection in heart transplant patients. The multi-center study by cardiologists from the United States, Sweden, Germany and Canada will be published in the June 30 issue of The New England Journal of Medicine.

Oregon Health


Please, click to subscribe to our Youtube Channel to be notified about upcoming health and food tips.